HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Consulting private health care providers aggravates treatment delay in urban South African tuberculosis patients.

AbstractSETTING:
An urban primary health care facility in Khayelitsha, South Africa.
OBJECTIVES:
To determine the difference in total tuberculosis (TB) treatment delay in patients who initially seek care at National TB Control Programme (NTP) facilities after the onset of TB-related symptoms, compared to patients who initially seek care from non-NTP health care practitioners (HCP); and to describe the relative contributions of diagnostic, treatment initiation, patient and health system (HS) delay.
DESIGN:
A cross-sectional study of adult TB patients treated by the NTP.
RESULTS:
A total of 210 patients (median age 31 years) were enrolled from May to December 2009: 46% were male, and 58% were human immunodeficiency virus (HIV) infected. The median duration of total delay was 31 days, diagnostic delay 26, treatment initiation delay 0, patient delay 8 and HS delay 17 days. Initial visit to a non-NTP HCP was independently associated with total (P = 0.007), HS (P = 0.014) and diagnostic delays (P = 0.012). HIV infection was an independent risk factor for total (P = 0.047) and HS delay (P = 0.021); 27% of patients reported first going to a non-NTP HCP.
CONCLUSION:
Initial care sought from non-NTP HCP was the main determinant of total, HS and diagnostic delays. Engagement and education of private HCPs is recommended.
AuthorsS S Van Wyk, D A Enarson, N Beyers, C Lombard, A C Hesseling
JournalThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease (Int J Tuberc Lung Dis) Vol. 15 Issue 8 Pg. 1069-76 (Aug 2011) ISSN: 1815-7920 [Electronic] France
PMID21740670 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antitubercular Agents
Topics
  • Adult
  • Antitubercular Agents (therapeutic use)
  • Chi-Square Distribution
  • Cross-Sectional Studies
  • Delayed Diagnosis (statistics & numerical data)
  • Female
  • Health Services Accessibility (statistics & numerical data)
  • Humans
  • Male
  • National Health Programs (statistics & numerical data)
  • Private Sector (statistics & numerical data)
  • Public Sector (statistics & numerical data)
  • Referral and Consultation (statistics & numerical data)
  • Regression Analysis
  • Risk Assessment
  • Risk Factors
  • South Africa (epidemiology)
  • Time Factors
  • Tuberculosis (diagnosis, drug therapy, epidemiology)
  • Urban Health Services (statistics & numerical data)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: